Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2026-01-03 @ 11:10 PM
Study NCT ID:
NCT05422027
Status:
RECRUITING
Last Update Posted:
2024-06-17
First Post:
2022-06-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma
Sponsor:
Xia Zhongjun
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ATG-010-IIT-MM-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |